IPX Relative Valuation
IPX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IPX is overvalued; if below, it's undervalued.
Historical Valuation
Iperionx Ltd (IPX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 133.11 is considered Overvalued compared with the five-year average of -26.16. The fair price of Iperionx Ltd (IPX) is between 14.98 to 34.29 according to relative valuation methord. Compared to the current price of 41.63 USD , Iperionx Ltd is Overvalued By 21.41%.
Relative Value
Fair Zone
14.98-34.29
Current Price:41.63
21.41%
Overvalued
-495.60
PE
1Y
3Y
5Y
Trailing
Forward
-93.03
EV/EBITDA
Iperionx Ltd. (IPX) has a current EV/EBITDA of -93.03. The 5-year average EV/EBITDA is -16.45. The thresholds are as follows: Strongly Undervalued below -73.75, Undervalued between -73.75 and -45.10, Fairly Valued between 12.20 and -45.10, Overvalued between 12.20 and 40.85, and Strongly Overvalued above 40.85. The current Forward EV/EBITDA of -93.03 falls within the Strongly Undervalued range.
-71.52
EV/EBIT
Iperionx Ltd. (IPX) has a current EV/EBIT of -71.52. The 5-year average EV/EBIT is -11.28. The thresholds are as follows: Strongly Undervalued below -46.74, Undervalued between -46.74 and -29.01, Fairly Valued between 6.45 and -29.01, Overvalued between 6.45 and 24.18, and Strongly Overvalued above 24.18. The current Forward EV/EBIT of -71.52 falls within the Strongly Undervalued range.
133.11
PS
Iperionx Ltd. (IPX) has a current PS of 133.11. The 5-year average PS is 27.82. The thresholds are as follows: Strongly Undervalued below -55.72, Undervalued between -55.72 and -13.95, Fairly Valued between 69.59 and -13.95, Overvalued between 69.59 and 111.37, and Strongly Overvalued above 111.37. The current Forward PS of 133.11 falls within the Strongly Overvalued range.
-102.46
P/OCF
Iperionx Ltd. (IPX) has a current P/OCF of -102.46. The 5-year average P/OCF is -26.67. The thresholds are as follows: Strongly Undervalued below -107.72, Undervalued between -107.72 and -67.19, Fairly Valued between 13.86 and -67.19, Overvalued between 13.86 and 54.39, and Strongly Overvalued above 54.39. The current Forward P/OCF of -102.46 falls within the Undervalued range.
-27.00
P/FCF
Iperionx Ltd. (IPX) has a current P/FCF of -27.00. The 5-year average P/FCF is -5.10. The thresholds are as follows: Strongly Undervalued below -19.48, Undervalued between -19.48 and -12.29, Fairly Valued between 2.10 and -12.29, Overvalued between 2.10 and 9.29, and Strongly Overvalued above 9.29. The current Forward P/FCF of -27.00 falls within the Strongly Undervalued range.
Iperionx Ltd (IPX) has a current Price-to-Book (P/B) ratio of 124.58. Compared to its 3-year average P/B ratio of 30.05 , the current P/B ratio is approximately 314.59% higher. Relative to its 5-year average P/B ratio of 22.63, the current P/B ratio is about 450.56% higher. Iperionx Ltd (IPX) has a Forward Free Cash Flow (FCF) yield of approximately -2.16%. Compared to its 3-year average FCF yield of -9.93%, the current FCF yield is approximately -78.22% lower. Relative to its 5-year average FCF yield of -9.18% , the current FCF yield is about -76.44% lower.
124.58
P/B
Median3y
30.05
Median5y
22.63
-2.16
FCF Yield
Median3y
-9.93
Median5y
-9.18
Competitors Valuation Multiple
The average P/S ratio for IPX's competitors is 23.04, providing a benchmark for relative valuation. Iperionx Ltd Corp (IPX) exhibits a P/S ratio of 133.11, which is 477.84% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IPX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IPX in the past 1 year is driven by Unknown.
People Also Watch

HCSG
Healthcare Services Group Inc
15.130
USD
+0.73%

EYE
National Vision Holdings Inc
23.760
USD
+4.53%

UXIN
Uxin Ltd
3.720
USD
+3.05%

CINT
Ci&T Inc
5.320
USD
+1.14%

TRIN
Trinity Capital Inc
15.915
USD
-0.22%

ERII
Energy Recovery Inc
14.220
USD
+0.28%

NEXA
Nexa Resources SA
4.820
USD
0.00%

SNCY
Sun Country Airlines Holdings Inc
12.260
USD
+0.49%

CAPL
Crossamerica Partners LP
20.180
USD
-0.54%

SKYH
Sky Harbour Group Corp
10.250
USD
-0.19%
FAQ

Is Iperionx Ltd (IPX) currently overvalued or undervalued?
Iperionx Ltd (IPX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 133.11 is considered Overvalued compared with the five-year average of -26.16. The fair price of Iperionx Ltd (IPX) is between 14.98 to 34.29 according to relative valuation methord. Compared to the current price of 41.63 USD , Iperionx Ltd is Overvalued By 21.41% .

What is Iperionx Ltd (IPX) fair value?

How does IPX's valuation metrics compare to the industry average?

What is the current P/B ratio for Iperionx Ltd (IPX) as of Aug 18 2025?

What is the current FCF Yield for Iperionx Ltd (IPX) as of Aug 18 2025?

What is the current Forward P/E ratio for Iperionx Ltd (IPX) as of Aug 18 2025?
